Peptides UK

Research Peptides UK Pinealon Peptide UK: EDR Evidence in the Peptides UK Market Pinealon is the name commonly used for the synthetic tripeptide Glu-Asp-Arg, abbreviated EDR. It belongs to a group of very short peptides developed within the Russian peptide-bioregulator research tradition. Laboratory studies have examined Pinealon in neuronal oxidative stress, hypoxia, dendritic-spine loss, DNA interactions, serotonin-related gene expression and cellular ageing. More recent research has also used human fibroblast-derived induced neurons. These studies create an interesting experimental hypothesis, but they do not establish Pinealon...

Research Peptides UK Kisspeptin-10 UK: Reproductive Hormone Research in the Peptides UK Market Kisspeptin-10 is a naturally occurring ten-amino-acid fragment of the KISS1 peptide family and a potent activator of the kisspeptin receptor. It plays a central role in experimental research into puberty, gonadotrophin-releasing hormone, luteinising hormone and reproductive physiology. Human studies demonstrate short-term hormonal activity, but Kisspeptin-10 is not an authorised UK fertility or hormone treatment and significant questions remain about chronic exposure, product quality and safety. Author: It’s Me & You Clinic Editorial...

Research Peptides UK KPV Peptide UK: Research Evidence in the Peptides UK Market KPV is a naturally occurring three-amino-acid fragment found at the C-terminal end of alpha-melanocyte-stimulating hormone. Laboratory and animal research has examined KPV in inflammatory signalling, intestinal transport, experimental colitis, airway epithelial responses and antimicrobial systems. Despite growing commercial interest, no controlled human exposure study has established its safety or effectiveness. Author: It’s Me & You Clinic Editorial Team Published: 21 July 2026 Last reviewed: 21 July 2026 Reading time: Approximately 24 minutes...

Research Peptides UK DSIP Peptide UK: Sleep Research in the Peptides UK Market Delta sleep-inducing peptide, commonly abbreviated to DSIP and formally known as emideltide, is a synthetic nine-amino-acid research peptide first described during experiments involving delta-wave sleep activity in rabbits. Human sleep studies were conducted mainly during the 1980s and early 1990s, but they involved small groups, inconsistent methods and mixed results. DSIP is not an authorised UK treatment for insomnia, narcolepsy, withdrawal, pain or another medical condition. Author: It’s Me & You Clinic...